Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kidney and brain protein (KIBRA), encoded by the WWC1 gene, is a postsynaptic scaffolding protein primarily expressed in the brain and kidneys. In the central nervous system, KIBRA plays a critical role in regulating synaptic plasticity and memory by stabilizing protein kinase Mzeta (PKMζ) and facilitating the trafficking of AMPA receptors to the postsynaptic membrane. Recent research has identified KIBRA as a novel target for synapse repair in Alzheimer's disease and other tauopathies, where its levels are significantly depleted in the brain but elevated in the cerebrospinal fluid. Therapeutic strategies focusing on restoring KIBRA signaling, such as the use of truncated CT-KIBRA peptides, have shown promise in reversing cognitive deficits and restoring synaptic function in animal models of neurodegeneration. Unlike many current Alzheimer's therapies that target amyloid or tau accumulation, KIBRA-based approaches aim to directly repair the synaptic damage that underlies memory loss.
Stabilization of PKMζ to promote postsynaptic AMPAR trafficking and restore synaptic plasticity
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kidney and brain protein (KIBRA) (KIBRA).